Literature DB >> 7529996

Identification of an immunodominant functional domain on human CD36 antigen using human-mouse chimaeric proteins and homologue-replacement mutagenesis.

L Daviet1, R Buckland, M D Puente Navazo, J L McGregor.   

Abstract

The human CD36 antigen is a multifunctional membrane glycoprotein that acts as a receptor for thrombospondin, malaria-infected erythrocytes and oxidized low-density lipoprotein, as well as being implicated in the recognition of apoptotic neutrophils by macrophages. OKM5 and other anti-CD36 monoclonal antibodies have been shown to inhibit these CD36 adhesive functions, suggesting that the monoclonal-antibody epitopes and the domains that mediate these events are closely related. Analysis of a series of chimaeric exchanges between human and mouse CD36 shows that six anti-CD36 monoclonal antibodies (OKM5, FA6-152, L103, 5F1, SM phi and 10/5) recognize epitopes within the domain comprising amino acids 155-183. A seventh monoclonal antibody (13/10) binds to another domain that spans amino acids 30-76. Homologue-replacement mutagenesis performed within the human 155-183 immunodominant sequence identifies key residues for the binding of three functional monoclonal antibodies (OKM5, FA6-152 and L103). The fact that antibodies directed against the 155-183 domain can inhibit adhesion suggests that this domain is directly involved in CD36-ligand binding.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7529996      PMCID: PMC1136452          DOI: 10.1042/bj3050221

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  20 in total

1.  CD36 peptides enhance or inhibit CD36-thrombospondin binding. A two-step process of ligand-receptor interaction.

Authors:  L L Leung; W X Li; J L McGregor; G Albrecht; R J Howard
Journal:  J Biol Chem       Date:  1992-09-05       Impact factor: 5.157

2.  Thrombospondin cooperates with CD36 and the vitronectin receptor in macrophage recognition of neutrophils undergoing apoptosis.

Authors:  J Savill; N Hogg; Y Ren; C Haslett
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

Review 3.  Membrane glycoprotein CD36: a review of its roles in adherence, signal transduction, and transfusion medicine.

Authors:  D E Greenwalt; R H Lipsky; C F Ockenhouse; H Ikeda; N N Tandon; G A Jamieson
Journal:  Blood       Date:  1992-09-01       Impact factor: 22.113

4.  High resolution functional analysis of antibody-antigen interactions.

Authors:  L Jin; B M Fendly; J A Wells
Journal:  J Mol Biol       Date:  1992-08-05       Impact factor: 5.469

5.  CD36-mediated signal transduction in human monocytes by anti-CD36 antibodies but not by anti-thrombospondin antibodies recognizing cell membrane-bound thrombospondin.

Authors:  B J Schüepp; H Pfister; K J Clemetson; R L Silverstein; T W Jungi
Journal:  Biochem Biophys Res Commun       Date:  1991-02-28       Impact factor: 3.575

6.  Antigenic and functional differences in adhesion of Plasmodium falciparum-infected erythrocytes to human and bovine CD36.

Authors:  C F Ockenhouse; N N Tandon; G A Jamieson; D E Greenwalt
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

7.  CD36 directly mediates cytoadherence of Plasmodium falciparum parasitized erythrocytes.

Authors:  P Oquendo; E Hundt; J Lawler; B Seed
Journal:  Cell       Date:  1989-07-14       Impact factor: 41.582

8.  Identification of monoclonal antibody epitopes and critical residues for rhinovirus binding in domain 1 of intercellular adhesion molecule 1.

Authors:  A McClelland; J deBear; S C Yost; A M Meyer; C W Marlor; J M Greve
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-15       Impact factor: 11.205

9.  CD36 is a receptor for oxidized low density lipoprotein.

Authors:  G Endemann; L W Stanton; K S Madden; C M Bryant; R T White; A A Protter
Journal:  J Biol Chem       Date:  1993-06-05       Impact factor: 5.157

10.  The binding site on ICAM-1 for Plasmodium falciparum-infected erythrocytes overlaps, but is distinct from, the LFA-1-binding site.

Authors:  A R Berendt; A McDowall; A G Craig; P A Bates; M J Sternberg; K Marsh; C I Newbold; N Hogg
Journal:  Cell       Date:  1992-01-10       Impact factor: 41.582

View more
  7 in total

Review 1.  CD36: implications in cardiovascular disease.

Authors:  Maria Febbraio; Roy L Silverstein
Journal:  Int J Biochem Cell Biol       Date:  2007-03-23       Impact factor: 5.085

2.  A sensitive immunoassay for rat fatty acid translocase (CD36) using phage antibodies selected on cell transfectants: abundant presence of fatty acid translocase/CD36 in cardiac and red skeletal muscle and up-regulation in diabetes.

Authors:  M M Pelsers; J T Lutgerink; F A Nieuwenhoven; N N Tandon; G J van der Vusse; J W Arends; H R Hoogenboom; J F Glatz
Journal:  Biochem J       Date:  1999-02-01       Impact factor: 3.857

3.  Formation of one or more intrachain disulphide bonds is required for the intracellular processing and transport of CD36.

Authors:  P Gruarin; R Sitia; M Alessio
Journal:  Biochem J       Date:  1997-12-01       Impact factor: 3.857

4.  Platelet-mediated clumping of Plasmodium falciparum-infected erythrocytes is a common adhesive phenotype and is associated with severe malaria.

Authors:  A Pain; D J Ferguson; O Kai; B C Urban; B Lowe; K Marsh; D J Roberts
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

5.  Molecular mechanistic insights into the endothelial receptor mediated cytoadherence of Plasmodium falciparum-infected erythrocytes.

Authors:  Ang Li; Tong Seng Lim; Hui Shi; Jing Yin; Swee Jin Tan; Zhengjun Li; Boon Chuan Low; Kevin Shyong Wei Tan; Chwee Teck Lim
Journal:  PLoS One       Date:  2011-03-17       Impact factor: 3.240

6.  CD36 mediates the In vitro inhibitory effects of thrombospondin-1 on endothelial cells.

Authors:  D W Dawson; S F Pearce; R Zhong; R L Silverstein; W A Frazier; N P Bouck
Journal:  J Cell Biol       Date:  1997-08-11       Impact factor: 10.539

7.  CD36-specific antibodies block release of HIV-1 from infected primary macrophages and its transmission to T cells.

Authors:  Stefano Berre; Raphaël Gaudin; Bruna Cunha de Alencar; Marion Desdouits; Mélanie Chabaud; Nadia Naffakh; Marc Rabaza-Gairi; François-Xavier Gobert; Mabel Jouve; Philippe Benaroch
Journal:  J Exp Med       Date:  2013-10-21       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.